Grifols SA A (EUR)
GRF
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range24.08 | 24.79
52-Wk Range- | -
Last Close24.71
Mkt Cap (m)14,566.04
Dividend yield0.81
ISINES0171996087
Volume733,904.00
Exchange VenueXMAD

Company Profile

Grifols SA is a pharmaceutical company. It primarily collects the liquid portion of human blood called plasma and then manufactures and sells plasma-derived products globally. It also operates diagnostics, hospital supplies, and raw materials businesses.

Key Information
Price/Earning30.51
Price/Book3.15
Price/Sales3.16
P/CF17.55
Rev Growth (3 year avg)7.98
EPS Growth (3 year avg)0.04
Operating Margin % 22.01
Net Margin %12.26
Return on Equity13.82
Debt/Equity1.47

Documents

Prospectus
en 23/04/2015
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.grifols.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)3,355.383,934.564,049.834,318.074,486.725,098.69
Operating Income (m)857.69970.37939.411,003.34994.121,122.39
Net Income (m)470.25532.15545.46662.70596.64625.15
Basic EPS0.690.780.800.970.870.91
Avg. Diluted Shares Outstanding (m)685.34685.66684.17684.24684.71685.12
Balance Sheet
EUR201420152016201720182019
Current Assets (m)2,913.123,089.473,122.512,945.323,483.255,362.18
Non Current Assets (m)5,536.636,512.247,007.267,974.958,993.8010,180.43
Total Assets (m)8,449.759,601.7210,129.7710,920.2612,477.0515,542.61
Current Liabilities (m)1,079.711,053.011,071.76977.991,257.321,366.56
Total Liabilities (m)------
Total Equity (m)2,658.123,296.203,721.483,629.084,225.554,822.12
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)978.93742.78553.28841.75737.43568.93
Capital Expenditure (m)-287.04-567.02-292.69-322.97-307.72-412.31
Figures are quoted in EUR unless stated otherwise
-0.48 (-1.94%)
24.23
Last Price